Mechanism and Function of Angiogenin in Hematopoietic Malignancy

Overview

Journal Zhongguo Sheng Wu Hua Xue Yu Fen Zi Sheng Wu Xue Bao

Specialty Biochemistry

Date 2016 Feb 16

PMID 26877599

Citations 2

Authors

Kevin A Goncalves

Guo-Fu Hu

Affiliations

Soon will be listed here.

Abstract

Angiogenic factors have been widely implicated in the formation and progression of solid tumors. A number of angiogenic mediators have been recently appreciated as having equivalent function in non-solid tumors, such as leukemia. One such factor, angiogenin (ANG), promotes tumor cell growth and angiogenesis in solid cancers; however its precise function(s) in hematological disorders are not fully understood. This review summarizes current knowledge of the function and therapeutic potential of angiogenic factors, with particular emphasis on the role and hypothesized mechanism of ANG in a non-solid tumor setting.

Citing Articles

Tumor Cell Survival Factors and Angiogenesis in Chronic Lymphocytic Leukemia: How Hot Is the Link?.

Ayoub M, Susin S, Bauvois B Cancers (Basel). 2025; 17(1.

PMID: 39796700 PMC: 11719013. DOI: 10.3390/cancers17010072.

Angiogenin (ANG)-Ribonuclease Inhibitor (RNH1) System in Protein Synthesis and Disease.

Sarangdhar M, Allam R Int J Mol Sci. 2021; 22(3).

PMID: 33525475 PMC: 7866052. DOI: 10.3390/ijms22031287.

Comparison of Proteome Composition of Serum Enriched in Extracellular Vesicles Isolated from Polycythemia Vera Patients and Healthy Controls.

Fel A, Lewandowska A, Petrides P, Wisniewski J Proteomes. 2019; 7(2).

PMID: 31064135 PMC: 6631625. DOI: 10.3390/proteomes7020020.

References

Moenner M, Gusse M, Hatzi E, Badet J . The widespread expression of angiogenin in different human cells suggests a biological function not only related to angiogenesis. Eur J Biochem. 1994; 226(2):483-90. DOI: 10.1111/j.1432-1033.1994.tb20073.x. View

Gilbert M, Dignam J, Armstrong T, Wefel J, Blumenthal D, Vogelbaum M . A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med. 2014; 370(8):699-708. PMC: 4201043. DOI: 10.1056/NEJMoa1308573. View

Di Raimondo F, Palumbo G, Molica S, Giustolisi R . Angiogenesis in chronic myeloproliferative diseases. Acta Haematol. 2002; 106(4):177-83. DOI: 10.1159/000046614. View

Katona T, Neubauer B, Iversen P, Zhang S, Baldridge L, Cheng L . Elevated expression of angiogenin in prostate cancer and its precursors. Clin Cancer Res. 2005; 11(23):8358-63. DOI: 10.1158/1078-0432.CCR-05-0962. View

Alexandrakis M, Passam F, Pappa C, Sfiridaki K, Tsirakis G, Damilakis J . Relation between bone marrow angiogenesis and serum levels of angiogenin in patients with myelodysplastic syndromes. Leuk Res. 2004; 29(1):41-6. DOI: 10.1016/j.leukres.2004.05.002. View

Oh S, Gotlib J . Antiangiogenic therapy in myelodysplastic syndromes: is there a role?. Curr Hematol Malig Rep. 2010; 3(1):10-8. DOI: 10.1007/s11899-008-0003-0. View

El-Kenawi A, El-Remessy A . Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales. Br J Pharmacol. 2013; 170(4):712-29. PMC: 3799588. DOI: 10.1111/bph.12344. View

Ribatti D, Vacca A, Nico B, Quondamatteo F, Ria R, Minischetti M . Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma. Br J Cancer. 1999; 79(3-4):451-5. PMC: 2362443. DOI: 10.1038/sj.bjc.6690070. View

Risau W, Drexler H, Mironov V, Smits A, Siegbahn A, Funa K . Platelet-derived growth factor is angiogenic in vivo. Growth Factors. 1992; 7(4):261-6. DOI: 10.3109/08977199209046408. View

10.

Daley G, Van Etten R, Baltimore D . Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science. 1990; 247(4944):824-30. DOI: 10.1126/science.2406902. View

11.

Krivtsov A, Twomey D, Feng Z, Stubbs M, Wang Y, Faber J . Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature. 2006; 442(7104):818-22. DOI: 10.1038/nature04980. View

12.

Molica S, Vitelli G, Levato D, Giannarelli D, Vacca A, Cuneo A . Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression. Eur J Haematol. 2004; 73(1):36-42. DOI: 10.1111/j.1600-0609.2004.00269.x. View

13.

Nguyen M, Watanabe H, Budson A, Richie J, Hayes D, Folkman J . Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst. 1994; 86(5):356-61. DOI: 10.1093/jnci/86.5.356. View

14.

Crawford Y, Ferrara N . Tumor and stromal pathways mediating refractoriness/resistance to anti-angiogenic therapies. Trends Pharmacol Sci. 2009; 30(12):624-30. DOI: 10.1016/j.tips.2009.09.004. View

15.

Molica S, Vacca A, Levato D, Merchionne F, Ribatti D . Angiogenesis in acute and chronic lymphocytic leukemia. Leuk Res. 2004; 28(4):321-4. DOI: 10.1016/j.leukres.2003.08.001. View

16.

Song G, Li Y, Jiang G . Role of VEGF/VEGFR in the pathogenesis of leukemias and as treatment targets (Review). Oncol Rep. 2012; 28(6):1935-44. DOI: 10.3892/or.2012.2045. View

17.

Panayiotidis P, Jones D, Ganeshaguru K, Foroni L, Hoffbrand A . Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro. Br J Haematol. 1996; 92(1):97-103. DOI: 10.1046/j.1365-2141.1996.00305.x. View

18.

Folkman J . Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995; 1(1):27-31. DOI: 10.1038/nm0195-27. View

19.

Brunner B, Gunsilius E, Schumacher P, Zwierzina H, Gastl G, Stauder R . Blood levels of angiogenin and vascular endothelial growth factor are elevated in myelodysplastic syndromes and in acute myeloid leukemia. J Hematother Stem Cell Res. 2002; 11(1):119-25. DOI: 10.1089/152581602753448586. View

20.

Kim J, Sohn S, Kim D, Baek J, Lee N, Suh J . Clinical implications of angiogenic factors in patients with acute or chronic leukemia: hepatocyte growth factor levels have prognostic impact, especially in patients with acute myeloid leukemia. Leuk Lymphoma. 2005; 46(6):885-91. DOI: 10.1080/10428190500054491. View